Similarly, the reduced expression of hepatic IκB by GalN/LPS injection was also reversed by 200 mg/kg cordycepin (Figure 3(e)), implying that cordycepin might exert its anti-inflammatory effect via decreasing TLR4 expression and inhibiting NFκB activation in GalN/LPS-induced acute liver injury. Here, NFKB1 is linked to injury.